Vitrafy Life Sciences Limited (VFY) has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets (>88% recovery vs >50% industry standard), cell & gene therapies (96% viability vs 70% industry minimum), aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems.
Find out what a historical investment in Vitrafy Life Sciences would be worth today using our VFY stock calculator.
Buying VFY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Vitrafy Life Sciences in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in VFY
What is the ticker symbol of Vitrafy Life Sciences?
The ticker symbol for Vitrafy Life Sciences is VFY.
How much is one share of VFY?
One share of VFY is valued at $2.31 as of 20 November 2026.
What is the market capitalisation of Vitrafy Life Sciences VFY?
As of 20 November 2026 Vitrafy Life Sciences has a market cap of $148.38M.
What is the P/E ratio of VFY?
The Price to Earnings ratio of VFY is -9.37.
What is the Earnings Per Share of VFY?
The Earnings Per Share of VFY is -$0.25.
What is the 52-week high for Vitrafy Life Sciences stock?
The Vitrafy Life Sciences 52-week high stock price is $4.66.
What is the 52-week low for Vitrafy Life Sciences stock?
The Vitrafy Life Sciences 52-week low stock price is $1.28.
Can I buy VFY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VFY shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.